Search research articles
Contact Us
Filters
Showing results (11-20 of 34) with videos related to
Page
of 4
Sort By:
Immunology and Cell Biology
|
May 4, 2016
Th17 cell differentiation proceeds independently of IRF8
Dane M Newman, Patrick Sk Leung, Tracy L Putoczki, et al.
The Journal of Experimental Medicine
|
January 24, 2002
Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development
Kazuyoshi Takeda, Mark J Smyth, Erika Cretney, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 4, 2006
IL-21 enhances tumor-specific CTL induction by anti-DR5 antibody therapy
Mark J Smyth, Yoshihiro Hayakawa, Erika Cretney, et al.
Immunologic Research
|
March 22, 2005
Are we really on the right TRAIL?
Erika Cretney, Adam P Uldrich, Stuart P Berzins, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 21, 2005
Cutting edge: TRAIL deficiency accelerates hematological malignancies
Nadeen Zerafa, Jennifer A Westwood, Erika Cretney, et al.
The Journal of Experimental Medicine
|
August 6, 2003
Normal thymocyte negative selection in TRAIL-deficient mice
Erika Cretney, Adam P Uldrich, Stuart P Berzins, et al.
Journal of Leukocyte Biology
|
October 25, 2008
Age-dependent, polyclonal hyperactivation of T cells is reduced in TNF-negative gld/gld mice
Florian Wiede, Alicia Roomberg, Erika Cretney, et al.
The Journal of Biological Chemistry
|
March 19, 2004
Granzyme M mediates a novel form of perforin-dependent cell death
Janice M Kelly, Nigel J Waterhouse, Erika Cretney, et al.
The Journal of Experimental Medicine
|
November 17, 2004
NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer
Mark J Smyth, Jeremy Swann, Janice M Kelly, et al.
Immunology and Cell Biology
|
September 22, 2005
TNF-related apoptosis-inducing ligand (TRAIL)/Apo2L suppresses experimental autoimmune encephalomyelitis in mice
Erika Cretney, Jonathan L McQualter, Nobuhiko Kayagaki, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 34) with videos related to
Sort By:
Page
of 4
Immunology and Cell Biology
|
May 4, 2016
Th17 cell differentiation proceeds independently of IRF8
Dane M Newman, Patrick Sk Leung, Tracy L Putoczki, et al.
The Journal of Experimental Medicine
|
January 24, 2002
Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development
Kazuyoshi Takeda, Mark J Smyth, Erika Cretney, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 4, 2006
IL-21 enhances tumor-specific CTL induction by anti-DR5 antibody therapy
Mark J Smyth, Yoshihiro Hayakawa, Erika Cretney, et al.
Immunologic Research
|
March 22, 2005
Are we really on the right TRAIL?
Erika Cretney, Adam P Uldrich, Stuart P Berzins, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 21, 2005
Cutting edge: TRAIL deficiency accelerates hematological malignancies
Nadeen Zerafa, Jennifer A Westwood, Erika Cretney, et al.
The Journal of Experimental Medicine
|
August 6, 2003
Normal thymocyte negative selection in TRAIL-deficient mice
Erika Cretney, Adam P Uldrich, Stuart P Berzins, et al.
Journal of Leukocyte Biology
|
October 25, 2008
Age-dependent, polyclonal hyperactivation of T cells is reduced in TNF-negative gld/gld mice
Florian Wiede, Alicia Roomberg, Erika Cretney, et al.
The Journal of Biological Chemistry
|
March 19, 2004
Granzyme M mediates a novel form of perforin-dependent cell death
Janice M Kelly, Nigel J Waterhouse, Erika Cretney, et al.
The Journal of Experimental Medicine
|
November 17, 2004
NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer
Mark J Smyth, Jeremy Swann, Janice M Kelly, et al.
Immunology and Cell Biology
|
September 22, 2005
TNF-related apoptosis-inducing ligand (TRAIL)/Apo2L suppresses experimental autoimmune encephalomyelitis in mice
Erika Cretney, Jonathan L McQualter, Nobuhiko Kayagaki, et al.
Page
of 4